Virax Biolabs Group Limited (VRAX) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

Virax Biolabs Group Limited (VRAX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.2M, listed on NASDAQ, employing roughly 17 people, carrying a beta of 1.05 to the broader market. Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. Led by James Foster, public since 2022-07-21.

IV/HV history compares implied volatility to realized volatility over time. No recent options activity for VRAX as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how implied vs realized volatility is reported and how to read the data →